Research map: Pan-cancer analysis identifies ODF2 as a dual prognostic and predictive biomarker for immunotherapy

Back to the article

Papers in this map

  1. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade · Dung Thi Le · 2017 · 6820 citations · Cited by this paper
  2. cGAS-STING pathway-related genes as candidate molecules associated with cervical intraepithelial neoplasia: an exploratory bioinformatics analysis · 2026 · Related
  3. The Immune Landscape of Cancer · Vésteinn Thórsson · 2018 · 6334 citations · Cited by this paper
  4. Pan-cancer analysis and spatial validation in endometrial cancer reveal CD3D as a prognostic and immunological biomarker · 2026 · Related
  5. TIMER2.0 for analysis of tumor-infiltrating immune cells · Taiwen Li · 2020 · 5797 citations · Cited by this paper
  6. Systems biology approach to gene network analysis identifies therapeutic and diagnostic targets in colorectal cancer · 2026 · Related
  7. Maftools: efficient and comprehensive analysis of somatic variants in cancer · Anand Mayakonda · 2018 · 5596 citations · Cited by this paper
  8. FXYD6 functions as a tumor suppressor in lung adenocarcinoma via the OIP5-AS1/miR-4735-3p/FXYD6 axis · 2026 · Related
  9. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics · Jianfang Liu · 2018 · 4062 citations · Cited by this paper
  10. RBM15-mediated ASPM m6A modification facilitates osteosarcoma progression via IGF2BP3-dependent manner · 2026 · Related
  11. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies · Jérôme Galon · 2019 · 3583 citations · Cited by this paper
  12. Differential expression of LYZ across pan-cancer and its prognostic value and immune microenvironment regulatory mechanisms in glioma · 2026 · Related
  13. Therapeutic cancer vaccines · Mansi Saxena · 2021 · 1590 citations · Cited by this paper
  14. Ion homeostasis related gene signature characterizes the immune landscape and predicts prognosis in lung adenocarcinoma · 2026 · Related
  15. The cancer-immunity cycle: Indication, genotype, and immunotype · Ira Mellman · 2023 · 961 citations · Cited by this paper
  16. Integrative multi-omics analysis reveals LLPS-associated CLEC2D⁺AR⁻ tumor-cell states linked to early adaptive progression toward castration resistance in prostate cancer · 2026 · Related
  17. First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study · Heinz-Josef Lenz · 2021 · 710 citations · Cited by this paper
  18. Global landscape and emerging trends of ubiquitination research in lung cancer based on a bibliometric analysis from 2000 to 2025 · 2026 · Related
  19. Therapeutic cancer vaccines: advancements, challenges and prospects · Ting Fan · 2023 · 582 citations · Cited by this paper
  20. Precision oncology for ALK positive inflammatory myofibroblastic tumor · 2026 · Related
  21. Odf2-deficient mother centrioles lack distal/subdistal appendages and the ability to generate primary cilia · Hiroaki Ishikawa · 2005 · 318 citations · Cited by this paper
  22. Coordinated Ciliary Beating Requires Odf2-Mediated Polarization of Basal Bodies via Basal Feet · Koshi Kunimoto · 2012 · 229 citations · Cited by this paper
  23. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors · Zaoqu Liu · 2023 · 152 citations · Cited by this paper
  24. Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer · Fangfang Bi · 2020 · 121 citations · Cited by this paper
  25. Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma · Han Gong · 2024 · 108 citations · Cited by this paper
  26. Outer dense fibre protein 2 (ODF2) is a self-interacting centrosomal protein with affinity for microtubules · Fatima F. Donkor · 2004 · 84 citations · Cited by this paper
  27. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer · Dawn Sijin Nin · 2023 · 75 citations · Cited by this paper
  28. Identification, structure, and agonist design of an androgen membrane receptor · Zhao Yang · 2025 · 70 citations · Cited by this paper
  29. NetAUC: A network-based multi-biomarker identification method by AUC optimization · Xing-Yi Li · 2021 · 55 citations · Cited by this paper
  30. CD4 + T and CD8 + T Cells in Uterus Exhibit Both Selective Dysfunction and Residency Signatures · Shuangpeng Kang · 2024 · 55 citations · Cited by this paper
  31. Impact of Omicron Variant Infection on Female Fertility and Laboratory Outcomes: A Self‐Controlled Study · Yu‐Ling Hu · 2024 · 41 citations · Cited by this paper
  32. Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer · Ping Yang · 2022 · 35 citations · Cited by this paper
  33. A novel GSH depletor for simultaneous ferroptosis and cuproptosis Activation in hepatocellular carcinoma · Haoyu Yang · 2025 · 33 citations · Cited by this paper
  34. Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response · Zhaoqi Zhang · 2025 · 28 citations · Cited by this paper
  35. Testis-specific serine/threonine protein kinase 4 (Tssk4) phosphorylates Odf2 at Ser-76 · Xiaoli Wang · 2016 · 26 citations · Cited by this paper
  36. Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers · Huihan Ai · 2023 · 26 citations · Cited by this paper
  37. Spatial heterogeneity of MDSCs mediated by ANXA1-FPRs signaling drives immune suppression in OSCC progression · Fengtian Li · 2026 · 19 citations · Cited by this paper
  38. Screening and identification of HLA-A2-restricted neoepitopes for immunotherapy of non-microsatellite instability-high colorectal cancer · Ranran Shi · 2021 · 13 citations · Cited by this paper
  39. Pan-cancer analysis identifies adhesion G protein-coupled receptor G6 as a potential prognostic and immunotherapeutic biomarker with its functional validation · Jinfeng Zhu · 2025 · 12 citations · Cited by this paper

Source: OpenAlex (CC0)